Literature DB >> 17264502

Role of bacterial and host factors in infectious endophthalmitis.

Meredith Gregory1, Michelle C Callegan, Michael S Gilmore.   

Abstract

Endophthalmitis is a frequent blinding complication of globe-penetrating injury and ocular surgery. The outcome of this intraocular infection depends both on the organism involved and management of the ensuing inflammation. The role of various toxins and bacterial factors in the pathogenesis of this infection is beginning to be delineated, but appears to be organism specific. Because of the immune-privileged environment of the eye, principles important in the resolution of infection at extraocular sites cannot be extrapolated to understanding the host-parasite dynamics in eye infection. Moreover, some factors that suppress the intraocular immune environment appear to have unexpected roles in activating phagocytic cells of the innate immune system in response to the presence of bacteria. Therefore, considerable additional information characterizing the precise role of bacterial and host factors in the pathogenesis of endophthalmitis will be required in order to develop new therapies to improve the outcome of this often blinding infection.

Entities:  

Mesh:

Year:  2007        PMID: 17264502     DOI: 10.1159/000099277

Source DB:  PubMed          Journal:  Chem Immunol Allergy        ISSN: 0079-6034


  13 in total

1.  Efficacy of vitrectomy in improving the outcome of Bacillus cereus endophthalmitis.

Authors:  Michelle C Callegan; Scott Guess; Nanette R Wheatley; Dustin C Woods; Gabe Griffin; Brandt J Wiskur; Robert Leonard
Journal:  Retina       Date:  2011-09       Impact factor: 4.256

Review 2.  Targets of immunomodulation in bacterial endophthalmitis.

Authors:  Frederick C Miller; Phillip S Coburn; Mursalin Md Huzzatul; Austin L LaGrow; Erin Livingston; Michelle C Callegan
Journal:  Prog Retin Eye Res       Date:  2019-05-28       Impact factor: 21.198

3.  Toll-like receptor 2 ligand-induced protection against bacterial endophthalmitis.

Authors:  Ashok Kumar; Christopher N Singh; Inna V Glybina; Tamer H Mahmoud; Fu-Shin X Yu
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

4.  TLR2 mediates the innate response of retinal Muller glia to Staphylococcus aureus.

Authors:  Nazeem Shamsuddin; Ashok Kumar
Journal:  J Immunol       Date:  2011-05-20       Impact factor: 5.422

5.  Essential Role of NLRP3 Inflammasome in Mediating IL-1β Production and the Pathobiology of Staphylococcus aureus Endophthalmitis.

Authors:  Ajay Kumar; Pawan Kumar Singh; Zeeshan Ahmed; Sukhvinder Singh; Ashok Kumar
Journal:  Infect Immun       Date:  2022-04-11       Impact factor: 3.609

6.  Increased resistance to Staphylococcus aureus endophthalmitis in BALB/c mice: Fas ligand is required for resolution of inflammation but not for bacterial clearance.

Authors:  Norito Sugi; Emily A Whiston; Bruce R Ksander; Meredith S Gregory
Journal:  Infect Immun       Date:  2013-04-08       Impact factor: 3.441

7.  Temporal retinal transcriptome and systems biology analysis identifies key pathways and hub genes in Staphylococcus aureus endophthalmitis.

Authors:  Deepa Rajamani; Pawan Kumar Singh; Bruce G Rottmann; Natasha Singh; Manoj K Bhasin; Ashok Kumar
Journal:  Sci Rep       Date:  2016-02-11       Impact factor: 4.379

8.  S-layer Impacts the Virulence of Bacillus in Endophthalmitis.

Authors:  Md Huzzatul Mursalin; Phillip S Coburn; Erin Livingston; Frederick C Miller; Roger Astley; Agnès Fouet; Michelle C Callegan
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-09-03       Impact factor: 4.799

9.  Role of Staphylococcus aureus Virulence Factors in Inducing Inflammation and Vascular Permeability in a Mouse Model of Bacterial Endophthalmitis.

Authors:  Ajay Kumar; Ashok Kumar
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

10.  Zebrafish are Resistant to Staphylococcus aureus Endophthalmitis.

Authors:  Frank Mei; Matthew Rolain; Xiao Yi Zhou; Pawan Kumar Singh; Ryan Thummel; Ashok Kumar
Journal:  Pathogens       Date:  2019-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.